<bill session="119" type="h" number="1620" updated="2025-11-18T16:03:51Z">
  <state datetime="2025-02-26">REFERRED</state>
  <status>
    <introduced datetime="2025-02-26"/>
  </status>
  <introduced datetime="2025-02-26"/>
  <titles>
    <title type="display">Finn Sawyer Access to Cancer Testing Act</title>
    <title type="short" as="introduced">Finn Sawyer Access to Cancer Testing Act</title>
    <title type="official" as="introduced">To facilitate the development of treatments for cancer, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001163"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2025-02-26"/>
    <cosponsor bioguide_id="B001257" joined="2025-02-26"/>
    <cosponsor bioguide_id="D000230" joined="2025-02-26"/>
    <cosponsor bioguide_id="G000583" joined="2025-05-21"/>
    <cosponsor bioguide_id="G000551" joined="2025-02-26"/>
    <cosponsor bioguide_id="H001047" joined="2025-02-26"/>
    <cosponsor bioguide_id="L000601" joined="2025-02-26"/>
    <cosponsor bioguide_id="P000597" joined="2025-11-10"/>
    <cosponsor bioguide_id="S001185" joined="2025-02-26"/>
    <cosponsor bioguide_id="T000460" joined="2025-02-26"/>
    <cosponsor bioguide_id="T000481" joined="2025-02-26"/>
    <cosponsor bioguide_id="T000469" joined="2025-11-07"/>
    <cosponsor bioguide_id="W000797" joined="2025-02-26"/>
  </cosponsors>
  <actions>
    <action datetime="2025-02-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-02-26" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2025-02-26">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referred To"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="119" type="s" number="755" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medicaid"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
    <term name="Poverty and welfare assistance"/>
    <term name="State and local government operations"/>
  </subjects>
  <amendments/>
  <summary date="2025-03-26T20:06:35Z" status="Introduced in House">Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.</summary>
</bill>
